Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

Documenti analoghi

• The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia
  di: Sagwa, Evans, et al.
  Pubblicazione: (2012)
• Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia
  di: Sagwa, Evans L, et al.
  Pubblicazione: (2016)
• Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort
  di: Sagwa, Evans L., et al.
  Pubblicazione: (2015)
• Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients
  di: Tetteh, Raymond A., et al.
  Pubblicazione: (2016)
• Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
  di: Schnippel, Kathryn, et al.
  Pubblicazione: (2016)